Table 4 Additional one-way sensitivity analyses for health care utilization parameters
From: Cost effectiveness of a pentavalent rotavirus vaccine in Oman
Payer perspective | Societal perspective | |
|---|---|---|
Scenario | Cost/QALY saved OMR (USD) | Cost/QALY saved OMR (USD) |
Base case scenario | 1,140 (2,964) | CS |
Vaccine administration Fee (1.44 OMR [USD 3.74]) | 2,051 (5,332.6) | 534 (1,388.4) |
Hospitalizations | ||
10% fewer than base case | 1,405 (3,653) | CS |
25% fewer than base case | 1,802 (4,685.2) | 353 (917.8) |
50% fewer than base case | 2,465 (6,409) | 1,084 (2,818.4) |
ED visits | ||
10% fewer than base case | 1,163 (3,023.8) | CS |
25% fewer than base case | 1,197 (3,112.2) | CS |
50% fewer than base case | 1,254 (3,260.4) | CS |
Outpatient visits | ||
10% fewer than base case | 1,225 (3,185) | CS |
25% fewer than base case | 1,353 (3,517.8) | CS |
50% fewer than base case | 1,565 (4,069) | 48 (124.8) |
Deaths | ||
10% fewer than base case | 1,201 (3,122.6) | CS |
25% fewer than base case | 1,306 (3,395.6) | CS |
50% fewer than base case | 1,527 (3,970.2) | CS |